glp-1 drugs venom weight-loss drugs: PA, NJ poison control centers see more calls Gila Monster Venom: The Unexpected

The ozempic segment dominated the market with a 32.15% market share in 2025 due to its strong clinical performance

So, please contact us today by calling 770-534-0110 and learn more about GLP-1s and the robotic bariatric surgical options that we offer and see what a difference they have already made for people like you.

When a term becomes popular before it becomes medically precise, patients can be left with the impression that a trend is more established than it really is

Many individuals with Hashimoto's thyroiditis experience weight gain as a consequence of reduced metabolic rate associated with hypothyroidism